Finance

Beta
Lists
8CB0:FRA
Cannara Biotech Inc
€1.00
0.00%
(0.00) 1D
Jun 2, 8:03:04 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 8CB0...
Mkt. cap
162.99M
Avg. vol.
308.00
Volume
0.00
52-wk high
€1.24
52-wk low
€0.68
No. of employees
452
Mkt. cap
162.99M
Avg. vol.
308.00
Volume
0.00
52-wk high
€1.24
52-wk low
€0.68
No. of employees
452
News stories
From sources across the web
About Cannara Biotech Inc
CEO-
Employees452
Founded2017
Headquarters-
SectorPersonal care products
Websitecannara.ca
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
May 2025
Aug 2025
Nov 2025
Feb 2026
Revenue
27.27M
28.52M
30.11M
27.15M
Cost of goods sold
14.45M
16.13M
18.90M
15.53M
Cost of revenue
14.45M
16.13M
18.90M
15.53M
Research and development expenses
176.94K
191.15K
287.45K
400.70K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.46M
6.02M
6.23M
6.50M
Operating expense
6.12M
7.30M
8.51M
8.25M
Total operating expenses
20.57M
23.43M
27.41M
23.78M
Operating income
6.70M
5.09M
2.70M
3.37M
Other non operating income
-60.86K
-379.12K
-73.54K
-93.55K
EBT including unusual items
5.79M
4.54M
2.04M
2.82M
EBT excluding unusual items
5.79M
4.00M
2.04M
2.94M
Income tax expense
1.65M
1.23M
1.00M
1.16M
Effective tax rate
28.49%
27.03%
49.07%
41.04%
Other operating expenses
-
-
-
-
Net income
4.14M
3.31M
1.04M
1.66M
Net profit margin
15.19%
11.62%
3.45%
6.12%
Earnings per share
-
-
-
0.02
Interest and investment income
62.19K
89.58K
82.70K
84.27K
Interest expense
-937.60K
-805.27K
-608.11K
-465.53K
Net interest expenses
-875.41K
-715.69K
-525.41K
-381.26K
Depreciation and amortization charges
-
-
266.74K
252.99K
EBITDA
7.89M
7.26M
4.22M
4.61M
Gain or loss from assets sale
-1.51K
-422.17K
-
122.01K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer